| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 02.03. | Symbiosis Appoints Joanne Anderson as Chief Commercial Officer | ||
| 02.03. | 3T Biosciences Taps Rebeca Villarreal-Barragan as Head of Clinical Operations | ||
| 27.02. | Lilly and Incyte's Olumiant Recommended in EU for Adolescents with Severe Alopecia Areata | ||
| 27.02. | Atrium Therapeutics Launches with $270M | ||
| 27.02. | WuXi XDC, Earendil Labs Partner to Accelerate the Development of ADCs | ||
| 26.02. | Validogen Launches Next-Gen Synthetic Methanol-Free Promoters | ||
| 26.02. | EU Selects SK bioscience, IDT Biologika, Vaxxas for Next-Gen Flu Vaccine Development | ||
| 26.02. | Boehringer Ingelheim Licenses Noval Oral Therapeutics Program from Sitryx | ||
| 26.02. | Quotient Sciences, Ispen Extend Commercial Manufacturing Pact | ||
| 26.02. | Asahi Kasei Acquires Aicuris | ||
| 26.02. | Brainlab, Precision NeuroMed Partner on AI-Enabled Drug Delivery to Brain | ||
| 25.02. | Shilpa Biologicals, SteinCares to Expand Biosimilar Access in Latin America | ||
| 25.02. | Nexus Precision Health Acquires Leal Health | ||
| 25.02. | CareDx Names COO to Additional CFO Post | ||
| 25.02. | Alkermes Announces CEO Succession Details | ||
| 25.02. | Schreiner MediPharm, OECHSLERhealth Introduce Cap-Lock for Vials | ||
| 25.02. | FDA Approves Pfizer's Braftovi Combination for First-Line Metastatic Colorectal Cancer | ||
| 25.02. | Asahi Kasei Enters Global License Agreement with Alchemedicine | ||
| 24.02. | Caidya Appoints Michael Clay COO | ||
| 24.02. | NorthX and Demeetra Align to Accelerate Biotech Company Milestones | ||
| 24.02. | Bruker, Noetik Expand Collaboration, Advance Foundational Models for Therapeutics Applications | ||
| 24.02. | Clinilabs Expands European Operations | ||
| 24.02. | Astellas Pharma, Vir Biotechnology Partner to Advance VIR-5500 | ||
| 24.02. | Avid Bioservices Opens Early Phase Center of Excellence in CA | ||
| 23.02. | Flamma USA Successfully Passes FDA Inspection |